Bakoulev Scientific Center for Cardiovascular Surgery, Russian Academy of Medical Sciences, Moscow, Russia.
Blood Purif. 2009;28(3):227-33. doi: 10.1159/000231988. Epub 2009 Aug 14.
The purpose of this publication is to evaluate the first experiences with the supplemental use of selective endotoxin adsorption cartridges in the treatment of critically ill patients complicated by severe sepsis after cardiac surgery.
Thirteen patients with Gram-negative sepsis underwent the procedure of selective lipopolysaccharide (LPS) adsorption using Alteco adsorber (group I) or Toraymyxin columns (polymyxin-B-immobilized fiber) (group II).
This therapy positively influenced the course of sepsis. After the second procedure, levels of serum endotoxin and procalcitonin markedly decreased in both groups. We also discovered a positive effect on leukocytosis levels and a trend towards normalization of body temperature, improvement of hemodynamic indices and increase of the lung's oxygenating function. Blood cultures taken several days after the procedure were negative.
Our experience with LPS adsorption shows some evidence for the potential efficacy of this method in the treatment of critically ill patients with sepsis. Further investigations are required.
本研究旨在评估在心脏手术后发生严重脓毒症的危重症患者的治疗中,补充使用选择性内毒素吸附剂的初步经验。
13 例革兰氏阴性菌脓毒症患者接受了 Alteco 吸附剂(I 组)或 Toraymyxin 柱(多粘菌素 B 固定纤维)(II 组)的选择性脂多糖(LPS)吸附治疗。
该治疗方法对脓毒症的病程有积极影响。在第二次治疗后,两组患者的血清内毒素和降钙素原水平均显著下降。我们还发现白细胞增多症水平有积极影响,体温有正常化趋势,血流动力学指标改善,肺的氧合功能增加。在治疗后数天采集的血培养均为阴性。
我们使用 LPS 吸附的经验表明,这种方法在治疗脓毒症危重症患者方面具有一定的疗效潜力。需要进一步的研究。